Information flow is important

World wide internet network

Often times, it is difficult to understand the role of a biomarker in a disease process. The signaling and biochemical networks within the cell are complex but when paired with other networks between cells and in a whole organism, the complexity goes up by significant dimensions.
To understand networks, there are various institutes using the network paradigm to understand stock markets social networks, and economic markets. Do the models developed with one of the networks help understand another network? Maybe not, though there are significant research dollars going into determining whether there is a crossover between internet networks and social networks or biological networks…. For example, understanding all the physical underpinnings of the neuronal pathways does not necessarily predict behavior. However, obvious breaks in networks might make the task easier to predict.
The one area that is fascinating is the internet. It is a complex network that is controlled by individual rules that helps derive the state but does it help predict any one server activity in a network?  Probably not…
In a biological network, a drug that disrupts the network may change the function of the network but is it possible to predict the change? Scientists hope that a subtle change in the network may be determined by observing a few key characteristics (biomarkers). However, it would be a computationally interesting problem to predict biomarkers without necessary knowing all the nodes in the network or very specific characteristics. Unfortunately, the current state of knowledge is to disrupt the network and analyze everything. Then hope you find the key characteristic that represents the altered state of the network.

 

Similar Posts

  • Liquid biopsy guidelines

    A term that was created in 2010 called “liquid biopsy” became the standard for much of the screening of cancer that is done using blood to check for cancer cells though the NCI definition is specific for cancer and used to include its applications in detecting cancer and determining therapeutic efficacy : https://www.cancer.gov/publications/dictionaries/cancer-terms/def/liquid-biopsy The first…

  • Multi-cancer early detection

    There have been so many multi-cancer early detection tests coming on the market and the users are generally not aware of them – each of them have a different capability and strengths. Genomeweb had done a survey of what are the tests available and how they are perceived. Look at the survey at : https://www.genomeweb.com/cancer/genomeweb-survey-enthusiasm-mced-tests-research-and-clinical-care-despite-evidence-caveats…

  • Prioritizing biomarkers

    When there are multiple biomarkers in a therapeutic study, how do you prioritize which one to use. One possibility is to use specific criteria. The easiest one of them is to select one that gives you the best signal/noise. A strong signal for your efficacy marker will enable you to detect small changes in the…

  • |

    Radiopharmaceuticals

    Development is complex: Usually are highly cancer specific, high persistent expression throughout the tumor and metastasis, readily accessible on the cell surface, not shed and thoroughly validated. Many isotopes are possible and many targets possible such as Nectin4, DLL3, FAP, Somatostatin receptors, PSMA, Integrins, CXCR4, Claudin 18.2, Norepinephrine transporter, EGFR2. Clearance from tumor will matter…

  • Considerations for analysis of clinical samples

    When diagnostic tests are implemented in clinical studies there are multiple considerations beyond just the assay and the analyte that are not generally considered but are important. For example: Sample collection, preparation and transport Standards need to be specified for pre-analysis that would specify the conditions needed even before the analysis are done. Selection of…